Nabumetone - 0615-7630-39 - (nabumetone)

Alphabetical Index


Drug Information of Nabumetone

Product NDC: 0615-7630
Proprietary Name: Nabumetone
Non Proprietary Name: nabumetone
Active Ingredient(s): 750    mg/1 & nbsp;   nabumetone
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Nabumetone

Product NDC: 0615-7630
Labeler Name: NCS HealthCare of KY, Inc dba Vangard Labs
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA078671
Marketing Category: ANDA
Start Marketing Date: 20080301

Package Information of Nabumetone

Package NDC: 0615-7630-39
Package Description: 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-7630-39)

NDC Information of Nabumetone

NDC Code 0615-7630-39
Proprietary Name Nabumetone
Package Description 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-7630-39)
Product NDC 0615-7630
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name nabumetone
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20080301
Marketing Category Name ANDA
Labeler Name NCS HealthCare of KY, Inc dba Vangard Labs
Substance Name NABUMETONE
Strength Number 750
Strength Unit mg/1
Pharmaceutical Classes Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]

Complete Information of Nabumetone


General Information